Medtronic Stops Sales Of Defibrillator Part

Law360, New York (October 15, 2007, 12:00 AM EDT) -- Medtronic Inc. announced Monday that it will no longer sell an electrical lead used in its implantable defibrillators because it may be prone to fracturing and has been identified as a possible factor in five deaths, though it does not recommended removing leads that have already been implanted.

The company has stopped selling its Sprint Fidelis lead, a component used to connect an implantable defibrillator to a patient's heart, and has recommended that doctors stop using them. When a lead fractures, it can cause the defibrillator...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.